Retrospective analysis of neoplasms in patients using angiotensin receptor blockers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Retrospective analysis of neoplasms in patients using angiotensin receptor blockers ; volume:14 ; number:1 ; day:9 ; month:7 ; year:2024 ; pages:1-7 ; date:12.2024
Scientific reports ; 14, Heft 1 (9.7.2024), 1-7, 12.2024
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-64867-y
- URN
-
urn:nbn:de:101:1-2409262121112.581564052738
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sharma, Arvind Kumar
- Rastogi, Shruti
- Goyal, Ramesh K.
- SpringerLink (Online service)
Other Objects (12)
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
Angiotensin receptor blockers in heart failure after the ELITE II trial
Intraoperative angioedema induced by angiotensin II receptor blocker: a case report
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report
Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
Angiotensin receptor blockers in heart failure after the ELITE II trial
Intraoperative angioedema induced by angiotensin II receptor blocker: a case report
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report
Angiotensin converting enzyme inhibitors versus receptor blockers in patients with ventricular tachyarrhythmias
Angiotensin Receptor Blockers and Cognition: a Scoping Review
Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in Cerebral Arteriogenesis
Contribution of angiotensin converting enzyme to angiotensin receptor blocker induced angio-oedema
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
Angiotensin receptor blockers in heart failure after the ELITE II trial
Intraoperative angioedema induced by angiotensin II receptor blocker: a case report
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report